View the historical price chart for HIMS to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Yes, HIMS stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether HIMS stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
HIMS presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 69.3%, though mid-large cap with growth potential.
Analyst sentiment is generally positive with 3 buy ratings vs 2 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 185.60, and consider their own risk tolerance and investment timeline.
Based on our comprehensive analysis of HIMS's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
Based on revenue growth analysis and market trends, hims stock is projected to reach $155.79 by 2030, representing a 205.2% increase from the current price of $51.05.
Get detailed analyst targets, key factors, and comprehensive forecast analysis
Analyze financial statements and market position
Review price charts and technical indicators
Evaluate market and company-specific risks
Consumer Defensive
Household & Personal Products
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a...
Make buy/hold/sell decision with price targets
Get detailed step-by-step analysis, risk assessment, and investment strategies
2269 Chestnut Street, San Francisco, CA 94123
United States
Get detailed executive information, governance metrics, and comprehensive corporate data